Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection

Cell Reports(2021)10.1016/j.celrep.2021.109538Source: DataRank Database

Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 87 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access87 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 12.36)OA: goldTopics (61)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Gaetano Faleo,Jessica Chavez ORCID,Michael S. Saxton,David I. Berrios ORCID,Natanya R. Kerper

Live enrichment

PubMed:34407395 OpenAlex:https://openalex.org/W3194648368

Juvenile Diabetes Research Foundation

Grant: 5-COE-2019-860-S-B

National Institutes of Health

Grant: P30 DK063720

Juvenile Diabetes Research Foundation United Kingdom

Grant: 2019-019

FWCI

12.36

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2211124721009724/pdf

publisherhttp://www.cell.com/article/S2211124721009724/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124721009724?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124721009724?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2021.109538

Fields of Study

Pancreatic function and diabetesImmune Cell Function and InteractionDiabetes and associated disordersAllelesAnimalsCell LineClone CellsGene DeletionGraft RejectionHLA AntigensHumansIslets of LangerhansKiller Cells, NaturalLymphocyte ActivationMaleMice, Inbred NODPluripotent Stem CellsT-LymphocytesMice

MeSH Terms

AllelesAnimalsCell LineClone CellsGraft RejectionHLA AntigensHumansIslets of LangerhansKiller Cells, NaturalLymphocyte ActivationMaleT-LymphocytesMice, Inbred NODGene DeletionPluripotent Stem CellsMice

Keywords

Induced pluripotent stem cellHuman leukocyte antigenImmune systemImmunologyBiologyIsletStem cellAntigenHumanized mousePancreatic isletsTransplantationGeneCell biologyGeneticsEmbryonic stem cellMedicineDiabetes mellitusbeta cell replacement therapycell therapydiabeteshuman leukocyte antigensimmune evasionimmune rejectionpancreatic beta cellsregenerative medicinestem cells

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus

10.6084/m9.figshare.20401409.v1figshare

Additional file 1 of Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus

10.6084/m9.figshare.20401409figshare

Additional file 2 of Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus

10.6084/m9.figshare.20401412.v1figshare

Additional file 2 of Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus

10.6084/m9.figshare.20401412figshare

Additional file 5 of Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus

10.6084/m9.figshare.20401421.v1figshare

Additional file 5 of Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus

10.6084/m9.figshare.20401421figshare

Additional file 6 of Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus

10.6084/m9.figshare.20401424.v1figshare

Additional file 6 of Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus

10.6084/m9.figshare.20401424figshare